Home Healthcare asia-pacific-health-screening-market

Healthcare

Image

Asia-Pacific Health Screening Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Oct 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 339
  • No of Figures: 57

Asia-Pacific Health Screening Market, By Test Type (Cholesterol Tests, Diabetes Test, Cancer Screening, General Check Up Test, STDs, Blood Pressure Test and Others), Package Type (Basic Health Screening, Senior Citizen Profile, Women Health Check, Men Health Check, Heart Check, Diabetes Check and Others), Panel Type (Multi-Test Panels and Single-Test Panels), Sample Type (Blood, Urine, Serum, Saliva and Others), Technology (Immunoassays, Medical Imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis) and Others), Condition (Cardiovascular Disease, Metabolic Disorders, Cancer, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions and Others), Sample Collection Sites (Hospital, Homes, Diagnostic Laboratories, Offices and Others), Distribution Channel (Direct Tenders, Retail Sales and Others), Country (Japan,  China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific) Industry Trends and Forecast to 2028.

Asia-Pacific Health Screening Market Market Analysis and Insights: Asia-Pacific Health Screening Market

Asia-Pacific health screening market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 13.6% in the forecast period of 2021 to 2028 and is expected to reach USD 109,704.00 million by 2028. The rising number of chronic diseases, geriatric population, and increasing awareness about early detection and treatment of disease are the major drivers that propelled the market's demand in the forecast period.

Health screening is an important method of early detection of a specific disorder. The screening tests are often used in preventative medicine to identify whether an individual shows early signs of a condition's risk factors. The disease, which may be detected by screening includes cancer, diabetes, high cholesterol, high blood pressure, and osteoporosis.

The rising awareness among people about early detection and treatment of disease and increasing health expenditure are increasing the demand for health screening.

Rising demand for health screening because of its efficacy, along with growing number of service providers, and increasing awareness campaign by private and public players of health screening are propelling the growth of the health screening market in the forecast period. However, the high cost of screening test may hamper the market growth in the forecast period.

The Asia-Pacific health screening market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Health Screening Market Asia-Pacific Health Screening Market Scope and Market Size

Asia-Pacific health screening market is segmented into eight notable segments based on test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. 

  • On the basis of test type, Asia-Pacific health screening market is segmented into cholesterol tests, diabetes test, cancer screening, general checkup test, STDs, blood pressure test, and others. In 2021, the cholesterol test segment is expected to dominate the market because of rise in geriatric population and sedentary lifestyle.
  • On the basis of package type, the Asia-Pacific health screening market is segmented into basic health screening, senior citizen profile, women health check, men health check, heart check, diabetes check, and others. In 2021, basic health screening segment is expected to dominate the market because of increasing healthcare expenditure in Asian countries.
  • On the basis of panel type, Asia-Pacific health screening market is segmented into multi-test panels and single-test panels. In 2021, multi-test panels segment is expected to dominate the market due to the technological advancement of laboratories in this region
  • On the basis of sample type, the Asia-Pacific health screening market is segmented into blood, urine, serum, saliva, and others. In 2021, blood segment is expected to dominate the market because it is the most type of sample and can diagnosed in almost every laboratory.
  • On the basis of technology, the Asia-Pacific health screening market is segmented into immunoassays, medical imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in situ hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis), and others. In 2021, immunoassays segment is expected to dominate the market because the Asian market is one of the emerging healthcare market with growing medical tourism which is expected to increase the demand for all screening technique in this reason
  • On the basis of condition, the Asia-Pacific health screening market is segmented into cardiovascular disease, metabolic disorders, cancer, inflammatory conditions, musculoskeletal disorders, neurological conditions, Hepatitis-C complications, immunology-related conditions, and others. In 2021, cardiovascular disease segment is expected to dominate the market because of high prevalence of cardiovascular diseases in this region also
  • On the basis of sample collection sites, the Asia-Pacific health screening market is segmented into hospitals, homes, diagnostic laboratories, offices, and others. In 2021, hospitals segment is expected to dominate the market as the infrastructure is growing in Asia-pacific region with increasing hospitals numbers
  • On the basis of distribution channel, the Asia-Pacific health screening market is segmented into direct tenders, retail sales, and others. In 2021, direct tender segment is expected to dominate the market because of increase in overall sales of health screening programs.

 Asia-Pacific Health Screening Market Country Level Analysis

Asia-Pacific health screening market is analyzed, and market size information is provided on the test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel.

The countries covered in the Asia-Pacific health screening market report are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific. India in the Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of innovative R&D and new product launches and approvals.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Rise in Geriatric Population and Increased Incidence of Cancer and CVD Diseases are Boosting the Market Growth of Asia-Pacific Health Screening Products 

Asia-Pacific health screening market also provides you with detailed market analysis for every country's growth in the health screening product industry with drugs sales, the impact of advancement, technology, and changes in regulatory scenarios with their support for the Health Screening market. The data is available for the historic period 2010 to 2019.

Competitive Landscape and Asia-Pacific Health Screening Market Share Analysis

The Asia-Pacific health screening market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the Asia-Pacific health screening market.

The major companies which are dealing in the Asia-Pacific health screening market are Sonic Healthcare Limited, Quest Diagnostics Incorporated, Healius Limited, Quidel Corporation, Eurofins Scientific, GRAIL, , Exact Sciences Corporation, SYNLAB International GmbH, UNILABS, LabPLUS, BioReference Laboratories, , ACM Global Laboratories, Cerba Healthcare, , Innova Medical Group, AMEDES Holding GmbH, RadNet, Inc., Natera, Inc., Trinity Biotech, Nuffield Health, RepeatDx, NeoGenomics Laboratories, H.U Group Holdings, Inc., Lifelabs, ARUP Laboratories, Q2 Solutions, Genova Diagnostics, Life Length, DNA Labs India, , Telomere Diagnostics, Charles River Laboratories, Ambry Genetics, SpectraCell Laboratories, Inc., Dr. Lal PathLabs, and Laboratory Corporation of America among others.

Many product launch and agreement are also initiated by the companies’ worldwide, which also accelerates the Asia-Pacific health screening market.

For instance,

  • In March 2020, Sonic healthcare announced that they have acquired Pathologie Hamburg- a pathology practice laboratory. This acquisition has provided the company with increased production and testing capabilities.In September2020, Healius Limited announced that it gone into sales agreement with Virtus Health to acquire adora Fertility. This will boost the market for the company in the forecast period.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the Health Screening market which also provides the benefit for organization to improve their offering for Health Screening.

SKU-

TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)

TABLE 2 NEW CANCER CASES FOR AGE 85+ IN U.S.

TABLE 3 ACCORDING TO THE UNITED NATIONS, IN 2019, THE TOTAL POPULATION OF AGED PEOPLE ABOVE 65 WAS 703 MILLION AND IS EXPECTED TO REACH 1.5 BILLION BY 2050.

TABLE 4 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)

TABLE 5 ASIA PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 6 ASIA PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 ASIA PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 8 ASIA PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 ASIA PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 10 ASIA PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 ASIA PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 12 ASIA PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 ASIA PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 14 ASIA PACIFIC REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 15 ASIA PACIFIC STD’S IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 ASIA PACIFIC STD’S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 17 ASIA PACIFIC BLOOD PRESSURE TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 20 ASIA PACIFIC HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 21 ASIA PACIFIC MULTI-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 ASIA PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 24 ASIA PACIFIC HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 25 ASIA PACIFIC BASIC HEALTH SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 ASIA PACIFIC SENIOR CITIZEN PROFILE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 ASIA PACIFIC WOMEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 ASIA PACIFIC MEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 ASIA PACIFIC HEART CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 ASIA PACIFIC DIABETES CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 33 ASIA PACIFIC BLOOD IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 ASIA PACIFIC URINE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 ASIA PACIFIC SERUM IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 ASIA PACIFIC SALIVA IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 ASIA PACIFIC HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 39 ASIA PACIFIC IMMUNOASSAYS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 ASIA PACIFIC MEDICAL IMAGING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 ASIA PACIFIC QPCR IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 ASIA PACIFIC QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 43 ASIA PACIFIC Q-FISH IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 ASIA PACIFIC Q-FISH IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 45 ASIA PACIFIC TRF (TERMINAL RESTRICTION FRAGMENT) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 ASIA PACIFIC STELA (SINGLE TELOMERE LENGTH ANALYSIS) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 47 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 48 ASIA PACIFIC HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 49 ASIA PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 50 ASIA PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 51 ASIA PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 52 ASIA PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 53 ASIA PACIFIC CANCER IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 54 ASIA PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 55 ASIA PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 56 ASIA PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 57 ASIA PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 58 ASIA PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 59 ASIA PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 60 ASIA PACIFIC IMMUNOLOGY-RELATED CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 61 ASIA PACIFIC HEPATITIS-C COMPLICATIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 62 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 63 ASIA PACIFIC HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 64 ASIA PACIFIC DIRECT TENDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 65 ASIA PACIFIC RETAIL SALES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 66 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 67 ASIA PACIFIC HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 68 ASIA PACIFIC HOSPITAL IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 69 ASIA PACIFIC HOSPITAL IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 70 ASIA PACIFIC HOME IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 71 ASIA PACIFIC DIAGNOSTIC LABORATORIES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 72 ASIA PACIFIC OFFICES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 73 ASIA PACIFIC OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 74 ASIA-PACIFIC HEALTH SCREENING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 75 ASIA-PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 76 ASIA-PACIFIC CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 77 ASIA-PACIFIC DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 78 ASIA-PACIFIC CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 79 ASIA-PACIFIC GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 80 ASIA-PACIFIC REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 81 ASIA-PACIFIC STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 82 ASIA-PACIFIC OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 83 ASIA-PACIFIC HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 84 ASIA-PACIFIC HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 85 ASIA-PACIFIC SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 86 ASIA-PACIFIC HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 87 ASIA-PACIFIC HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 88 ASIA-PACIFIC QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 89 ASIA-PACIFIC Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 90 ASIA-PACIFIC HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 91 ASIA-PACIFIC CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 92 ASIA-PACIFIC METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 93 ASIA-PACIFIC INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 94 ASIA-PACIFIC MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 95 ASIA-PACIFIC NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 96 ASIA-PACIFIC HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 97 ASIA-PACIFIC HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 98 ASIA-PACIFIC HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 99 CHINA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 100 CHINA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 101 CHINA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 102 CHINA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 103 CHINA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 104 CHINA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 105 CHINA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 106 CHINA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 107 CHINA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 108 CHINA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 109 CHINA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 110 CHINA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 111 CHINA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 112 CHINA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 113 CHINA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 114 CHINA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 115 CHINA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 116 CHINA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 117 CHINA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 118 CHINA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 119 CHINA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 120 CHINA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 121 CHINA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 122 CHINA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 123 JAPAN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 124 JAPAN CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 125 JAPAN DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 126 JAPAN CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 127 JAPAN GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 128 JAPAN REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 129 JAPAN STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 130 JAPAN OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 131 JAPAN HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 132 JAPAN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 133 JAPAN SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 134 JAPAN HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 135 JAPAN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 136 JAPAN QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 137 JAPAN Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 138 JAPAN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 139 JAPAN CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 140 JAPAN METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 141 JAPAN INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 142 JAPAN MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 143 JAPAN NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 144 JAPAN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 145 JAPAN HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 146 JAPAN HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 147 INDIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 148 INDIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 149 INDIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 150 INDIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 151 INDIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 152 INDIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 153 INDIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 154 INDIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 155 INDIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 156 INDIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 157 INDIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 158 INDIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 159 INDIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 160 INDIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 161 INDIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 162 INDIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 163 INDIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 164 INDIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 165 INDIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 166 INDIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 167 INDIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 168 INDIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 169 INDIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 170 INDIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 171 SOUTH KOREA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 172 SOUTH KOREA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 173 SOUTH KOREA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 174 SOUTH KOREA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 175 SOUTH KOREA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 176 SOUTH KOREA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 177 SOUTH KOREA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 178 SOUTH KOREA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 179 SOUTH KOREA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 180 SOUTH KOREA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 181 SOUTH KOREA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 182 SOUTH KOREA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 183 SOUTH KOREA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 184 SOUTH KOREA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 185 SOUTH KOREA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 186 SOUTH KOREA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 187 SOUTH KOREA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 188 SOUTH KOREA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 189 SOUTH KOREA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 190 SOUTH KOREA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 191 SOUTH KOREA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 192 SOUTH KOREA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 193 SOUTH KOREA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 194 SOUTH KOREA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 195 AUSTRALIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 196 AUSTRALIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 197 AUSTRALIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 198 AUSTRALIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 199 AUSTRALIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 200 AUSTRALIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 201 AUSTRALIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 202 AUSTRALIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 203 AUSTRALIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 204 AUSTRALIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 205 AUSTRALIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 206 AUSTRALIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 207 AUSTRALIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 208 AUSTRALIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 209 AUSTRALIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 210 AUSTRALIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 211 AUSTRALIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 212 AUSTRALIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 213 AUSTRALIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 214 AUSTRALIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 215 AUSTRALIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 216 AUSTRALIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 217 AUSTRALIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 218 AUSTRALIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 219 SINGAPORE HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 220 SINGAPORE CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 221 SINGAPORE DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 222 SINGAPORE CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 223 SINGAPORE GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 224 SINGAPORE REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 225 SINGAPORE STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 226 SINGAPORE OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 227 SINGAPORE HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 228 SINGAPORE HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 229 SINGAPORE SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 230 SINGAPORE HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 231 SINGAPORE HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 232 SINGAPORE QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 233 SINGAPORE Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 234 SINGAPORE HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 235 SINGAPORE CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 236 SINGAPORE METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 237 SINGAPORE INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 238 SINGAPORE MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 239 SINGAPORE NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 240 SINGAPORE HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 241 SINGAPORE HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 242 SINGAPORE HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 243 THAILAND HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 244 THAILAND CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 245 THAILAND DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 246 THAILAND CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 247 THAILAND GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 248 THAILAND REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 249 THAILAND STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 250 THAILAND OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 251 THAILAND HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 252 THAILAND HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 253 THAILAND SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 254 THAILAND HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 255 THAILAND HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 256 THAILAND QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 257 THAILAND Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 258 THAILAND HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 259 THAILAND CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 260 THAILAND METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 261 THAILAND INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 262 THAILAND MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 263 THAILAND NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 264 THAILAND HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 265 THAILAND HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 266 THAILAND HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 267 MALAYSIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 268 MALAYSIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 269 MALAYSIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 270 MALAYSIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 271 MALAYSIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 272 MALAYSIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 273 MALAYSIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 274 MALAYSIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 275 MALAYSIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 276 MALAYSIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 277 MALAYSIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 278 MALAYSIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 279 MALAYSIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 280 MALAYSIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 281 MALAYSIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 282 MALAYSIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 283 MALAYSIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 284 MALAYSIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 285 MALAYSIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 286 MALAYSIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 287 MALAYSIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 288 MALAYSIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 289 MALAYSIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 290 MALAYSIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 291 INDONESIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 292 INDONESIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 293 INDONESIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 294 INDONESIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 295 INDONESIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 296 INDONESIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 297 INDONESIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 298 INDONESIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 299 INDONESIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 300 INDONESIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 301 INDONESIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 302 INDONESIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 303 INDONESIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 304 INDONESIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 305 INDONESIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 306 INDONESIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 307 INDONESIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 308 INDONESIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 309 INDONESIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 310 INDONESIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 311 INDONESIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 312 INDONESIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 313 INDONESIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 314 INDONESIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 315 PHILIPPINES HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 316 PHILIPPINES CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 317 PHILIPPINES DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 318 PHILIPPINES CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 319 PHILIPPINES GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 320 PHILIPPINES REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 321 PHILIPPINES STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 322 PHILIPPINES OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 323 PHILIPPINES HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 324 PHILIPPINES HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 325 PHILIPPINES SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 326 PHILIPPINES HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 327 PHILIPPINES HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 328 PHILIPPINES QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 329 PHILIPPINES Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 330 PHILIPPINES HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 331 PHILIPPINES CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 332 PHILIPPINES METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 333 PHILIPPINES INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 334 PHILIPPINES MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 335 PHILIPPINES NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 336 PHILIPPINES HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 337 PHILIPPINES HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 338 PHILIPPINES HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 339 REST OF ASIA-PACIFIC HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

BROWSE RELATED REPORTS

Global Cellular Health Screening Market – Industry Trends and Forecast to 2029
Global Health Screening Market – Industry Trends and Forecast to 2031
Europe Health Screening Market – Industry Trends and Forecast to 2028
North America Health Screening Market – Industry Trends and Forecast to 2028
Middle East and Africa Health Screening Market – Industry Trends and Forecast to 2028

BROWSE RELATED Blogs

Increasing Incidence of Chronic Diseases is Boosting the Growth of the Market

BROWSE RELATED Press Release

Technological Advancements in Health Screening is Increasing the Growth of the Global Health Screening Market Size
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries

Buy Now
Request for TOC Speak to Analyst Inquire Before Buying Free Sample Report
Advance Formative Research Customization Request for bulk Reports

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials

David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Image
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Image
Business Intelligence and Analytics,
Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst,
Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director,
Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,
A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director,
Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager,
Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations,
GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst,
Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager,
Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment
MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer
Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro
Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future